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Abstract
The requirement for health and social care workers to self-isolate when they or their household 
contacts develop symptoms consistent with SARS-CoV-2 infection can lead to critical staff shortages 
in the context of a pandemic. In this report we describe the implementation of a drive-through 
testing service in a single NHS region in Scotland. From 17th March 2020 to 11th April 2020 1890 
SARS-CoV-2 rtPCR tests were performed. 22% of tests were positive. Allowing the remaining 78% of 
staff to return to work within 24 hours was estimated to save over 8000 working days during the 
peak pandemic period. 
https://mc.manuscriptcentral.com/thorax
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Health and social care workers (HSCW) are disproportionately infected with SARS-CoV-2. Healthcare 
workers accounted for 21% of cases of SARS during the 2002 outbreak1, and recent experience in 
China and Italy confirms high rates of healthcare worker infections during the current pandemic.2,3 In 
addition to the direct effects of the virus on HSCWs, infections have indirect effects on their families 
and staff morale and can have a significant impact on the ability of healthcare systems to function 
due to staff absence. Current UK guidance requires that HSCWs experiencing symptoms should be 
absent from work for 7 days, while if they live with a symptomatic household contact (SHC), the staff 
member should be absent from work for 14 days to account for the incubation period of the virus. 
Rapid availability of testing to exclude SARS-CoV-2 infection would allow critical healthcare staff to 
return to work. 
In this letter we describe the results of a testing programme for symptomatic HSCWs and SHCs in a 
single UK region (Tayside, Scotland). The testing service was established 17th March 2020 as the first 
in the country and was initiated by local clinicians and NHS Tayside management. Samples were 
collected at a drive-through testing hub at a local community hospital with the testing site selected 
as it was remote from the main University teaching hospital and provided adequate vehicle access, 
parking and testing facilities.4,5 At the time of writing the facility employs 55 staff. The site was 
available to any staff within the Tayside region. While the majority of staff are resident in Dundee, 
some staff from the wider region would have had to travel 20-30 miles to access the site. The 
definition of HSCWs included all key workers such as doctors, nurses, pharmacists, porters, 
healthcare assistants, paramedics and social care staff particularly those working in care homes or in 
the community. The testing model can be seen in Figure 1. Combined nasal-pharyngeal swabs were 
taken for rtPCR as previously described.6 HSCWs were able to return to work following a negative 
test with results available within 24 hours. Days of staff absence potentially saved were therefore 
calculated as the average number of working days following a negative test (up to a maximum of 6 
days for staff members and 13 days in the case of SHCs). A worse-case scenario in which testing only 
saved 3 days and 10 days was also calculated (in this scenario a HSCW developing symptoms during 
a weekend would self-isolate for 3 days before they could receive testing and a further day while 
awaiting the results of the test).7
From 17th March 2020 to 11th April, 1890 tests were performed by the service. 3 individuals were 
tested more than once and therefore 1887 individuals were tested. In 1173 cases (62.1%), the HSCW 
themselves was tested, in 374 cases (19.8%) an adult SHC was tested. In 155 cases a child SHC was 
tested (8.2%). In 188 cases (9.9%) it could not be determined whether a HSCW or SHC was tested. 
325/1173 (27.7%) HSCWs, 73/374 (19.5%) adult contacts and 4/155 (2.6%) child contacts tested 
positive for SARS-CoV-2. 15 of 188 undetermined cases were positive (8.0%). Clinical information 
https://mc.manuscriptcentral.com/thorax
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was available for 1727 HSCWs and SHCs. The most frequently reported symptom was cough 
1369/1727 (79.3%) followed by fever 619 (35.8%), sore throat 294 (17.0%) and shortness of breath 
97 (5.6%). Anosmia was not part of the original case definition and was not collected. Data on 
ethnicity was not collected, but data from 2019 showed that the NHS Tayside workforce was 97% 
white. Based on the reported isolation time in each case and a typical 40 hour working week, we 
estimate that testing therefore prevented up to 3634 lost work days from HSCW testing, 2795 from 
adult SHC testing and 1402 lost work days from child SHC testing.  
Assuming a worst-case scenario in which all 188 undetermined cases were HSCWs, rather than SHCs, 
this equates to 8573 lost working days prevented through testing. Under the more conservative 
scenario where the majority of symptoms developed at weekends or staff had a longer delay to 
obtain testing, the saving was estimated at 6679 days. At the time of writing there were no cases in 
which negative HSCWs subsequently tested positive for the disease. No healthcare-associated 
outbreaks linked to staff that had been previously tested were reported during the study period.
To our knowledge, this is the first report of a systematic testing programme for HSCWs and SHCs 
across a healthcare region designed to ensure healthcare system resilience by reducing sickness 
absence. The results show a striking saving of over 8000 lost working days for health and social care 
staff over a period of just 3 weeks which is likely to have had a significant impact on the ability of 
health systems to respond to the SARS-CoV-2 pandemic. Inclusion of symptomatic household 
contacts in the testing programme accounted for more than 50% of the estimated work days saved 
is a key difference between this programme and others that have reported in the UK.8  The risk of 
SARS-CoV-2 infection can have an important effect on mental health and rapid access to testing may 
be an important part of mitigating these effects.9 There are some important considerations when 
implementing a staff testing programme. Firstly, nasopharyngeal and oropharyngeal swabs have 
been reported to have a sensitivity ranging from 63% to 90%10.11 It is therefore theoretically possible 
that some individuals tested in our study returned to work with a “false-negative” result. We 
acknowledge this is a risk, but this small risk must be balanced against the risk of decimating the 
healthcare workforce during a pandemic. It is acknowledged that the precise number of working 
days saved through this practice is difficult to estimate as not all HCSWs would be working full time 
and on all days during the isolation periods, and may not always be tested on the first day of 
symptoms which leads us to overestimate days saved. Therefore the estimates provided should be 
treated with caution but likely represent the maximum utility of a healthcare working testing 
programme. Future studies evaluating testing programmes such as this should consider 
incorporating a simple questionnaire including information about full vs part time work and number 
of HSCWs in the household to allow more accurate estimates in future. The ability to perform over 
https://mc.manuscriptcentral.com/thorax
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1800 rtPCR tests for SARS-CoV-2 is only possible if there is sufficient testing capacity. A prioritisation 
process for SARS-CoV-2 testing was implemented in the region during this period with 5 levels of 
testing 1- Patients with suspected COVID19 infection with clinical need for testing 2- symptomatic 
HSCWs or SHCs 3- asymptomatic HSCWs or patients-residents in the context of an outbreak 4- 
Sampling for admissions and transfers between acute, social care and community settings 5- other 
screening such as surveillance in inpatients over the age of 70. Testing capacity was not exceeded 
and therefore rationing of testing was not required. A limitation to the drive through testing model 
is that it requires access to a vehicle and may therefore exclude some staff. Alternative testing 
models are needed to enable access for all staff. 
Maintaining adequate staffing of the social care sector, wards, intensive care units and primary care 
assessment units is important during a pandemic and we demonstrate that screening of healthcare 
workers and symptomatic household contacts can markedly reduce the number of staff work days 
lost due to self-isolation. 
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Figure 1. Process for requesting testing and reporting results. Abbreviations CTT= community testing 
team, This illustrates the requirements for a successful testing programme including 1) Clear criteria 
for referral for testing 2) Sufficient adequately trained staff to perform testing 3) a suitable location 
to set-up a drive through testing hub 4) A robust process for managing and reporting back results to 
staff members 5) sufficient testing capacity to process staff RT-PCR tests 6) Ability to adapt the 
service to changing epidemiology, staff needs and case definitions in the context of an outbreak.  
https://mc.manuscriptcentral.com/thorax
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Figure 1. Process for requesting testing and reporting results. 
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